Request the sponsor/site notice, safety follow-up plan, unblinding policy if applicable, access to records and options for continued clinical care. Do not assume a cancellation means an individual child did or did not benefit.
What this means in real life
A trial can pause for a safety review, manufacturing issue, regulatory request, enrollment decision or business reason. A pause does not by itself prove that the treatment harmed or helped a particular participant. A cancellation or site closure can interrupt dosing, but safety follow-up and access to medical records may continue.
Ask the site for the sponsor or investigator notice in writing and for plain-language explanation of what stops and what continues. Clarify medication, immune-suppression or procedure follow-up; whom to call for adverse symptoms; whether scheduled tests remain covered; and how records transfer if the site closes. Participants may remain blinded, depending on the protocol and reason for the pause.
Withdrawal from research should not end ordinary DMD care. Contact the treating clinic promptly to rebuild a clinical plan, especially if trial participation changed other treatments. Do not start or restart excluded medicines without both teams coordinating.
A practical checklist
- ✓
Obtain the official notice and current participant instructions.
- ✓
Confirm dosing, monitoring and emergency-contact changes.
- ✓
Request copies of relevant records and test results.
- ✓
Coordinate resumption or adjustment of standard care with the DMD clinic.
- ✓
Ask how families will receive future safety updates and study results.
Questions to bring with you
Use these at the clinic, school meeting, equipment evaluation, program interview or benefits call. Write down the answers and who owns the next step.
- Why was the study paused or closed, and what is known versus unknown?
- What medical follow-up is still required and paid for?
- Will participants be unblinded, and when?
- Is continued or expanded access possible or promised?
- Who is responsible if the local site permanently closes?
Important context
Individual needs, eligibility and safety can differ. Confirm the plan with the relevant Duchenne-experienced clinician, therapist, school team or program before acting.
Sources used for this guide
Direct links are included so families can check the original guidance and bring it to qualified professionals.
Content review: July 18, 2026. Medical labels, trials, benefits and programs can change after publication.
Did this article answer the question?
A thumbs-down sends the article to the private administrator dashboard for review.